Enrolling: Bateman-Horne Center Biomarker Study

Who: Lucinda BatemanBateman-Horne
What: Participants will:

  • Receive a comprehensive clinical evaluation
  • Answer questionnaires
  • Provide blood samples
  • Commit to a yearly visit to Bateman-Horne in Salt Lake City, Utah (3-5 years, e.g.)

Information will be shared with multiple research groups searching for biomarkers for FM and ME/CFS.

How to participate: Click here to start the research eligibility form. (If this does not work, click on the link under ‘additional information’).
 
When: Ongoing
 
Where:  Salt Lake City, Utah, USA
 
Additional information:  Click here to see all of Bateman-Horne’s recruiting studies.
Facebook
Twitter
WhatsApp
Email

1 thought on “Enrolling: Bateman-Horne Center Biomarker Study”

  1. Susan Richardson-James

    Good afternoon
    I would love to be able to contribute to research (apart from financially as I am unfit to work at this time).
    Would you know of anywhere in the UK that are running trials at the moment.
    My case is quite complex and may be of interest to researchers.
    Many thanks
    Susan

Comments are closed.

Latest News

Text across top of image reads: "Experts in infection associated chronic illness" with "WE WANT YOU!" bolded below it. Hand with finger pointed out at viewer. "Apply now" buttons to the left and right with mouse cursor clicking on them.

Infection-associated chronic disease experts needed at ARPA-H

Congress launched ARPA-H (the Advanced Research Projects Agency for Health) this past March to focus on high-risk, high-reward research projects with the goal to solve intractable health problems. As ARPA-H is in the process of hiring its first cohort of program managers, #MEAction and a coalition of chronic disease advocacy groups have published an open

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top